Results 211 to 220 of about 83,919 (279)

Equine botulism

open access: yesEquine Veterinary Journal, Volume 58, Issue 2, Page 333-347, March 2026.
Abstract Botulism is a severe and often fatal disease in equine patients worldwide. Clostridium botulinum is a ubiquitous soil organism which produces a potent neurotoxin resulting in neuromuscular blockade and flaccid paralysis in affected animals. Definitive diagnosis is often impractical or impossible, leading to diagnosis and treatment based on ...
Kali Slavik   +2 more
wiley   +1 more source

Plasma C‐reactive protein and interleukin‐6 concentrations in foals during health and respiratory disease

open access: yesEquine Veterinary Journal, Volume 58, Issue 2, Page 372-379, March 2026.
Abstract Background Early and specific diagnosis of bronchopneumonia in foals is important to prevent severe disease. In human medicine, C‐reactive protein (CRP) and interleukin‐6 (IL‐6) are important diagnostic and prognostic biomarkers in neonatal pneumonia in other species.
Dorothea Hildebrandt   +3 more
wiley   +1 more source

The potential value of cytokine, cortisol and vitamin D profiles in foals from birth to weaning for respiratory disease prediction on a farm endemic for Rhodococcus equi pneumonia

open access: yesEquine Veterinary Journal, Volume 58, Issue 2, Page 359-371, March 2026.
Abstract Background Rhodococcus equi causes pneumonia in young foals, but disease susceptibility and severity vary. Cortisol and vitamin D modulate immune responses and cytokine production during bacterial infection, and altered concentrations are associated with sepsis in neonatal foals. We hypothesised an age and disease effect on circulating steroid
Londa J. Berghaus   +4 more
wiley   +1 more source

Pharmacokinetics and Safety of a Single Subcutaneous or Intramuscular Dose of Ketamine in Healthy Horses

open access: yesJournal of Veterinary Pharmacology and Therapeutics, Volume 49, Issue 2, Page 141-149, March 2026.
ABSTRACT Pharmacokinetics (PK) of intramuscular (IM) and subcutaneous (SC) ketamine in horses has not been described. This study aimed to evaluate the PK and safety of ketamine and its metabolites after a single SC or IM administration. In Phase 1, two horses received 0.5 or 1 mg/kg of ketamine via SC and IM routes.
Ana Rangel   +5 more
wiley   +1 more source

Management of Haws Syndrome in Cats With Gastrointestinal Diet: A Case Series

open access: yesVeterinary Ophthalmology, Volume 29, Issue 2, March 2026.
ABSTRACT Background Haws syndrome (HS) in cats is characterized by bilateral protrusion of the third eyelid and ptosis, often accompanied by gastrointestinal (GI) symptoms such as diarrhea. Emerging evidence suggests disruption of the gut‐brain axis, linked to GI microbiota dysbiosis, may play a role in HS development.
Bar Fruchter   +5 more
wiley   +1 more source

Dexmedetomidine Prolongs the Duration of Ropivacaine Corneal Anesthesia After Subconjunctival Injection in Healthy Horses

open access: yesVeterinary Ophthalmology, Volume 29, Issue 2, March 2026.
ABSTRACT Objective To determine whether dexmedetomidine prolongs corneal anesthesia following subconjunctival ropivacaine injection in healthy equine eyes. Methods Ten horses with normal ophthalmic exams were enrolled in a randomized, blinded, crossover experiment with a minimum 4‐week washout between treatments. Baseline corneal touch thresholds (CTT,
Sera Lee   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy